WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American ...

GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).

“Arriving at the intersection of effective BPH treatment, patient priorities and available technology can be a daunting task,” said Mr. Olly Kayes, MD, Honorary Senior Lecturer at the University of ...

Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of Fox 17. Aquablation therapy is a new type of surgical treatment for benign prostatic ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for ...

PROCEPT BioRobotics Corporation announced that its Aquablation therapy has been assigned a Category I Current Procedural Terminology (CPT) code, which will take effect on January 1, 2026. This marks a ...

In both single-specialty urology and multi-specialty ASCs, longer, more complex procedures can be a good fit and good for profitability. The key for either type of facility is having a dedicated ...

Pooled outcomes in more than 330 UroLift ® System subjects treated in a controlled setting were analyzed and reported by Claus Roehrborn et. al. PUL with the UroLift ® System was durable in most ...